{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:10:02Z","timestamp":1756314602459,"version":"3.44.0"},"reference-count":20,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,10,19]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>A 52-year-old woman was diagnosed with unresectable gallbladder neuroendocrine carcinoma (GB-NEC) exhibiting lymph node and peritoneal metastases, and received eight courses of chemotherapy with irinotecan plus cisplatin. Radiological examinations revealed significant regression of the GB tumour and disappearance of metastatic lesions, so the patient underwent laparoscopic cholecystectomy. However, the patient presented with multiple haemorrhagic brain metastases (BMs) and died 13 months after the initial diagnosis despite neurosurgical interventions. Pathological examination of the resected gallbladder demonstrated an extensive fibrous scar along with tubular adenocarcinoma components, which may indicate that the chemotherapy eliminated a pre-existing neuroendocrine carcinoma (NEC) component. Furthermore, pathological analysis confirmed that the BMs comprised NEC. In patients with advanced GB-NEC, conversion surgery may be a reasonable option if a first-line chemotherapy leads to downstaging of the tumour. Second-line drug therapy and systemic screening might also be considered in cases with BMs.<\/jats:p>","DOI":"10.1136\/bcr-2020-238114","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T15:46:13Z","timestamp":1606751173000},"page":"e238114","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Brain metastasis from gallbladder neuroendocrine carcinoma"],"prefix":"10.1136","volume":"13","author":[{"given":"Hanako","family":"Sasaki","sequence":"first","affiliation":[{"name":"Neurosurgery, Osaka Rosai Hospital, Sakai, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Goto","sequence":"additional","affiliation":[{"name":"Pathology, Osaka Rosai Hospital, Sakai, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Hirao","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Osaka Rosai Hospital, Sakai, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Neurosurgery, Osaka Rosai Hospital, Sakai, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"2025082709501200000_13.11.e238114.1","doi-asserted-by":"publisher","DOI":"10.1159\/000443172"},{"key":"2025082709501200000_13.11.e238114.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"2025082709501200000_13.11.e238114.3","first-page":"8218","article-title":"Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"2025082709501200000_13.11.e238114.4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds276"},{"key":"2025082709501200000_13.11.e238114.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0843-6"},{"key":"2025082709501200000_13.11.e238114.6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/CMAR.S227501","article-title":"Clinical analysis of 15 cases of gallbladder neuroendocrine carcinoma and comparison with gallbladder adenocarcinoma using a propensity score matching","volume":"12","author":"Yan","year":"2020","journal-title":"Cancer Manag Res"},{"key":"2025082709501200000_13.11.e238114.7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/jcm9010273","article-title":"Mixed neuroendocrine Non-Neuroendocrine neoplasms: a systematic review of a controversial and underestimated diagnosis","volume":"9","author":"Frizziero","year":"2020","journal-title":"J Clin Med"},{"key":"2025082709501200000_13.11.e238114.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-012-1212-4"},{"key":"2025082709501200000_13.11.e238114.9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.5858\/arpa.2015-0102-RS","article-title":"Primary biliary mixed Adenoneuroendocrine carcinoma (MANEC): a short review","volume":"140","author":"Acosta","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"2025082709501200000_13.11.e238114.10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","article-title":"Mixed Neuroendocrine-Nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms","volume":"27","author":"La Rosa","year":"2016","journal-title":"Endocr Pathol"},{"key":"2025082709501200000_13.11.e238114.11","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12473"},{"key":"2025082709501200000_13.11.e238114.12","doi-asserted-by":"publisher","DOI":"10.1159\/000443167"},{"key":"2025082709501200000_13.11.e238114.13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26124"},{"key":"2025082709501200000_13.11.e238114.14","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0470"},{"key":"2025082709501200000_13.11.e238114.15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12328-019-01053-y","article-title":"Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence","volume":"13","author":"Kamei","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"2025082709501200000_13.11.e238114.16","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/cncr.20659","article-title":"Carcinoid metastasis to the brain","volume":"101","author":"Hlatky","year":"2004","journal-title":"Cancer"},{"key":"2025082709501200000_13.11.e238114.17","doi-asserted-by":"publisher","DOI":"10.1159\/000287277"},{"key":"2025082709501200000_13.11.e238114.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5559-7","article-title":"Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome","volume":"19","author":"Krug","year":"2019","journal-title":"BMC Cancer"},{"key":"2025082709501200000_13.11.e238114.19","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.2018.78.6186","article-title":"Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase III, noninferiority, randomized controlled trial","volume":"36","author":"Kayama","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025082709501200000_13.11.e238114.20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25425"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:50:18Z","timestamp":1756313418000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,30]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bcr-2020-238114"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238114","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}